Rajnish Wellness Ltd

Rajnish Wellness Ltd., a micro-cap pharmaceutical company engaged in selling consumer durables and ayurvedic personal care products, reported deeply troubling results for Q4 FY26 (January-March 2026), with net losses ballooning to ₹4.70 crores despite a dramatic 338.68% quarter-on-quarter revenue surge. The loss marks a stark reversal from the previous quarter's loss of ₹0.91 crores and represents a staggering 1,624.8% deterioration compared to the average of the preceding four quarters.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 20 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Rajnish Wellness Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 13 April 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weak valuation metrics, signalling heightened risk for investors amid ongoing operational challenges.

Rajnish Wellness Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 April 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge of over 10% and improved technical trend contrast with its ongoing operational losses and poor long-term growth metrics.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.39, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance issues.

Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.0.39 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance issues.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 January 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Rajnish Wellness Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹49.75 crores, reported a net loss of ₹0.91 crores in Q3 FY26 (October-December 2025), marking a dramatic reversal from the modest profit of ₹0.06 crores posted in the previous quarter. The loss represents a concerning deterioration in profitability despite a robust 93.67% quarter-on-quarter revenue surge to ₹23.24 crores.

Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 January 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 04 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.